about
Promoter methylation analysis of WNT/β-catenin pathway regulators and its association with expression of DNMT1 enzyme in colorectal cancer.The prognostic effect of PTEN expression status in colorectal cancer development and evaluation of factors affecting it: miR-21 and promoter methylationPolymorphism in the interleukin-17A promoter contributes to gastric cancer.Use of integrase-minus lentiviral vector for transient expression.Increased Expression of Two Alternative Spliced Variants of CD1d Molecule in Human Gastric Cancer.Inhibition of HIV-1 by a Lentiviral Vector with a Novel Tat-Inducible Expression System and a Specific Tropism to the Target Cells.Expression levels of vascular endothelial growth factors a and C in patients with peptic ulcers and gastric cancer.Haptoglobin polymorphism in individuals with type 2 diabetic microangiopathy.Impact of hepcidin antimicrobial peptide on iron overload in tuberculosis patients.Determination of parasitic load in different tissues of murine toxoplasmosis after immunization by excretory-secretory antigens using Real time QPCR.A rapid and reliable genotyping method for hepatitis B virus genotypes (A-H) using type-specific primers.Novel functional polymorphism in IGF-1 gene associated with multiple sclerosis: A new insight to MS.The prognostic impact of EGFR, ErbB2 and MET gene amplification in human gastric carcinomas as measured by quantitative Real-Time PCR.Investigation of Trace Elements in the Hair and Nail of Patients with Stomach CancerA novel screening system based on gene targeting to enrich the modified mammalian cells: without leaving selection marker and additional sequenceThe correction of ETV6/RUNX1 translocation in acute lymphocytic leukemia cells: a new gene targeting system by homologous recombination mechanismDesign and construction of a recombinant lentiviral vector with specific tropism to human epidermal growth factor-overexpressed cancer cells: Developing a new retargeting system for lentivirus vectorsAlpha-globin gene mutation spectrum in patients with microcytic hypochromic anemia from Mazandaran Province, Iran
P50
Q34544597-10F78405-DAB3-40EE-B10C-ED2571939911Q36476282-537339CC-F608-4A03-B0AF-93678CE9A69CQ37162474-745157EF-6302-4567-82C0-27F768AAC451Q39178834-89E18411-F536-4B07-8769-B54F29CCD5A1Q41135689-6BFCCF34-34CD-4FD0-BAA0-B94684F21E4EQ41159088-4EE66BEB-775C-40FA-8038-5E2126D89EBBQ41695649-559255B6-2FC2-4C32-9337-9C6C0326AE70Q42001856-288CFFAF-B3B0-41B1-B27D-9E58E2AB913FQ42201402-599CDAFC-9DED-4ACF-8C82-CA93517720A3Q45287630-9AA6E2F6-4C45-41FC-82B7-AB6A6174486CQ45359571-4AE32495-B463-4567-BEA4-8A4E1601A7B4Q50713149-4E6B2470-F04B-461D-AF46-36F633192B65Q53562884-F43C4F46-3D8B-4137-971C-4BB569F086A8Q57487007-CD425133-03DC-4262-ABFF-9E7C9D1B54B5Q90005107-46ED726A-C6C2-434A-812D-820307A06FE1Q90645627-00F6FFAC-BD97-421B-8F18-25BE50832734Q91725619-8F0B1F41-BD05-404A-839D-6F35363B4069Q93066809-E3A588EE-BE32-4EF2-A4AA-FC9CACE29ED7
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Touraj Farazmandfar
@ast
Touraj Farazmandfar
@en
Touraj Farazmandfar
@es
Touraj Farazmandfar
@nl
Touraj Farazmandfar
@sl
type
label
Touraj Farazmandfar
@ast
Touraj Farazmandfar
@en
Touraj Farazmandfar
@es
Touraj Farazmandfar
@nl
Touraj Farazmandfar
@sl
prefLabel
Touraj Farazmandfar
@ast
Touraj Farazmandfar
@en
Touraj Farazmandfar
@es
Touraj Farazmandfar
@nl
Touraj Farazmandfar
@sl
P1053
L-5409-2017
L-5418-2017
P106
P1153
37116620900
P21
P31
P3829
P496
0000-0002-8207-6572
P569
2000-01-01T00:00:00Z